Results 41 to 50 of about 4,854,757 (315)

Temporary Mechanical Circulatory Support for Refractory Cardiogenic Shock Before Left Ventricular Assist Device Surgery

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
Background There are limited data on the role of temporary mechanical circulatory support (MCS) devices for cardiogenic shock before left ventricular assist device (LVAD) surgery.
Saraschandra Vallabhajosyula, Shilpkumar Arora, Sopan Lahewala, Varun Kumar, Ghanshyam P. S. Shantha, Jacob C. Jentzer, John M. Stulak, Bernard J. Gersh, Rajiv Gulati, Charanjit S. Rihal, Abhiram Prasad, Abhishek J. Deshmukh   +11 more
doaj   +1 more source

Climate therapy and the development of South Africa as a health resort, c.1850–1910

Bulletin of Geography. Socio-Economic Series, 2021
Historical research is undeveloped concerning tourism in sub-Saharan Africa. This research contributes to scholarship about the history of tourism for climate and health.
Rogerson Christian M., Rogerson Jayne M.
doaj   +1 more source

Randomized trial of a left ventricular assist device as destination therapy versus guideline‐directed medical therapy in patients with advanced heart failure. Rationale and design of the SWEdish evaluation of left Ventricular Assist Device (SweVAD) trial

European Journal of Heart Failure, 2020
Patients with advanced heart failure (AdHF) who are ineligible for heart transplantation (HTx) can become candidates for treatment with a left ventricular assist device (LVAD) in some countries, but not others.
K. Karason, L. Lund, M. Dalén, Erik Björklund, K. Grinnemo, O. Braun, J. Nilsson, H. Wal, J. Holm, L. Hübbert, K. Lindmark, B. Szabó, E. Holmberg, G. Dellgren   +13 more
semanticscholar   +1 more source

Cardiac Assist Devices: Early Concepts, Current Technologies, and Future Innovations

Bioengineering, 2019
Congestive heart failure (CHF) is a debilitating condition that afflicts tens of millions of people worldwide and is responsible for more deaths each year than all cancers combined. Because donor hearts for transplantation are in short supply, a safe and
Jooli Han, Dennis R. Trumble
doaj   +1 more source

Left Ventricular Assistant Device in End Stage Heart Failure as A Step of Heart Transplantation Center: A Case Report [PDF]

Journal of Cardio-Thoracic Medicine, 2023
With increasing prevalence of patients with advanced heart failure (AHF), increasing amount of readmission frequencies, duration of maximum medical therapy, and the 50% mortality during one-year, Left ventricular assist devices (LVAD) are considered to ...
Yasser Mubarak
doaj   +1 more source

Novel antigens of CAR T cell therapy: New roads; old destination

Translational Oncology, 2021
Chimeric antigen receptor T cell (CAR-T) therapy has so far proved itself as a reliable therapeutic option for the treatment of relapsed/refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL), diffuse large B-cell lymphoma (DLBCL), multiple myeloma
Pooria Safarzadeh Kozani, Pouya Safarzadeh Kozani, Fatemeh Rahbarizadeh   +2 more
doaj   +1 more source

Continuous flow left ventricular assist devices: a valid option for heart failure patients

Swiss Medical Weekly, 2012
Recent outstanding clinical advances with new mechanical circulatory systems (MCS) have led to additional strategies in the treatment of end stage heart failure (HF).
Thierry Carrel, Lars Englberger, Michele Vittorio Martinelli, Jukka Takala, Claudia Boesch, Vilborg Sigurdadottir, Erich Gygax, Alexander Kadner, Paul Mohacsi   +8 more
doaj   +1 more source

Transplant Outcomes in Destination Therapy Left Ventricular Assist Device Patients

ASAIO journal (1992), 2020
Left ventricular assist devices (LVAD) can be implanted as either a bridge to transplantation (BTT) or destination therapy (DT). This definition is fluid, as some DT patients undergo transplantation.
Robert J. H. Miller, Y. Moayedi, Abhinav Sharma, F. Haddad, W. Hiesinger, Dipanjan Banerjee   +5 more
semanticscholar   +1 more source

5-year results of a newly implemented mechanical circulatory support program for terminal heart failure patients in a Swiss non-cardiac transplant university hospital

Journal of Cardiothoracic Surgery, 2021
Background In Switzerland, long-term circulatory support programs have been limited to heart transplant centers. In 2014, to improve the management of patients with end-stage heart failure not eligible for transplantation, we implemented a left ...
Thibault Schaeffer, Otmar Pfister, Constantin Mork, Paul Mohacsi, Florian Rueter, Simon Scheifele, Anne Morgen, Urs Zenklusen, Thomas Doebele, Markus Maurer, Joachim Erb, Jens Fassl, Nadine Cueni, Martin Siegemund, Hans Pargger, Brigitta Gahl, Stefan Osswald, Friedrich Eckstein, Martin Grapow   +18 more
doaj   +1 more source

35. With full antiplatelet and anticoagulant coverage: Still aortic root and left main coronary artery thrombosis can occur early post left ventricular assist device implantation

Journal of the Saudi Heart Association, 2016
We describe a case of 39 years old male underwent continuous flow LVAD implantation (HeartWare) HVAD as destination therapy (DT) for severe left ventricular dysfunction ,moderate right ventricular dysfunction and severe pulmonary hypertension , presented
M. alassal
doaj   +1 more source